Literature DB >> 15528729

The cag pathogenicity island of Helicobacter pylori is disrupted in the majority of patient isolates from different human populations.

Farhana Kauser1, Aleem A Khan, M Abid Hussain, Ian M Carroll, Naheed Ahmad, Santosh Tiwari, Yogesh Shouche, Bimal Das, Mahfooz Alam, S Mahaboob Ali, C M Habibullah, Rafaela Sierra, Francis Megraud, Leonardo A Sechi, Niyaz Ahmed.   

Abstract

The cag pathogenicity island (cag-PAI) is one of the major virulence determinants of Helicobacter pylori. The chromosomal integrity of this island or the lack thereof is speculated to play an important role in the progress of the gastroduodenal pathology caused by H. pylori. We determined the integrity of the cag-PAI by using specific flanking and internally anchored PCR primers to know the biogeographical distribution of strains carrying fully integral cag-PAI with proinflammatory behavior in vivo. Genotypes based on eight selected loci were studied in 335 isolates obtained from eight different geographic regions. The cag-PAI appeared to be disrupted in the majority of patient isolates throughout the world. Conservation of cag-PAI was highest in Japanese isolates (57.1%). However, only 18.6% of the Peruvian and 12% of the Indian isolates carried an intact cag-PAI. The integrity of cag-PAI in European and African strains was minimal. All 10 strains from Costa Rica had rearrangements. Overall, a majority of the strains of East Asian ancestry were found to have intact cag-PAI compared to strains of other descent. We also found that the cagE and cagT genes were less often rearranged (18%) than the cagA gene (27%). We attempted to relate cag-PAI rearrangement patterns to disease outcome. Deletion frequencies of cagA, cagE, and cagT genes were higher in benign cases than in isolates from severe ulcers and gastric cancer. Conversely, the cagA promoter and the left end of the cag-PAI were frequently rearranged or deleted in isolates linked to severe pathology. Analysis of the cag-PAI genotypes with a different biogeoclimatic history will contribute to our understanding of the pathogen-host interaction in health and disease.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15528729      PMCID: PMC525253          DOI: 10.1128/JCM.42.11.5302-5308.2004

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  48 in total

1.  Interleukin-1 polymorphisms associated with increased risk of gastric cancer.

Authors:  E M El-Omar; M Carrington; W H Chow; K E McColl; J H Bream; H A Young; J Herrera; J Lissowska; C C Yuan; N Rothman; G Lanyon; M Martin; J F Fraumeni; C S Rabkin
Journal:  Nature       Date:  2000-03-23       Impact factor: 49.962

2.  Helicobacter pylori activates mitogen-activated protein kinase cascades and induces expression of the proto-oncogenes c-fos and c-jun.

Authors:  T Meyer-ter-Vehn; A Covacci; M Kist; H L Pahl
Journal:  J Biol Chem       Date:  2000-05-26       Impact factor: 5.157

3.  Differences in genotypes of Helicobacter pylori from different human populations.

Authors:  D Kersulyte; A K Mukhopadhyay; B Velapatiño; W Su; Z Pan; C Garcia; V Hernandez; Y Valdez; R S Mistry; R H Gilman; Y Yuan; H Gao; T Alarcón; M López-Brea; G Balakrish Nair; A Chowdhury; S Datta; M Shirai; T Nakazawa; R Ally; I Segal; B C Wong; S K Lam; F O Olfat; T Borén; L Engstrand; O Torres; R Schneider; J E Thomas; S Czinn; D E Berg
Journal:  J Bacteriol       Date:  2000-06       Impact factor: 3.490

4.  Altered states: involvement of phosphorylated CagA in the induction of host cellular growth changes by Helicobacter pylori.

Authors:  E D Segal; J Cha; J Lo; S Falkow; L S Tompkins
Journal:  Proc Natl Acad Sci U S A       Date:  1999-12-07       Impact factor: 11.205

5.  Determination of Helicobacter pylori virulence by simple gene analysis of the cag pathogenicity island.

Authors:  T Ikenoue; S Maeda; K Ogura; M Akanuma; Y Mitsuno; Y Imai; H Yoshida; Y Shiratori; M Omata
Journal:  Clin Diagn Lab Immunol       Date:  2001-01

Review 6.  Towards deciphering the Helicobacter pylori cytotoxin.

Authors:  J M Reyrat; V Pelicic; E Papini; C Montecucco; R Rappuoli; J L Telford
Journal:  Mol Microbiol       Date:  1999-10       Impact factor: 3.501

Review 7.  Pathogenicity islands and the evolution of microbes.

Authors:  J Hacker; J B Kaper
Journal:  Annu Rev Microbiol       Date:  2000       Impact factor: 15.500

8.  Molecular epidemiology of Helicobacter pylori in England: prevalence of cag pathogenicity island markers and IS605 presence in relation to patient age and severity of gastric disease.

Authors:  R J Owen; T M Peters; R Varea; E L Teare; S Saverymuttu
Journal:  FEMS Immunol Med Microbiol       Date:  2001-02

9.  Distribution of open reading frames of plasticity region of strain J99 in Helicobacter pylori strains isolated from gastric carcinoma and gastritis patients in Costa Rica.

Authors:  A Occhialini; A Marais; R Alm; F Garcia; R Sierra; F Mégraud
Journal:  Infect Immun       Date:  2000-11       Impact factor: 3.441

10.  Fine-structure molecular typing of Irish Helicobacter pylori isolates and their genetic relatedness to strains from four different continents.

Authors:  Ian M Carroll; Niyaz Ahmed; Sarah M Beesley; Aleem A Khan; Sheikh Ghousunnissa; Colm A O Moráin; Cyril J Smyth
Journal:  J Clin Microbiol       Date:  2003-12       Impact factor: 5.948

View more
  39 in total

1.  The "Costa Rican enigma" of Helicobacter pylori CagA and gastric cancer.

Authors:  Shingo Tsuji
Journal:  J Gastroenterol       Date:  2006-07       Impact factor: 7.527

2.  Comparing genomes of Helicobacter pylori strains from the high-altitude desert of Ladakh, India.

Authors:  Farhana Kauser; M Abid Hussain; Irshad Ahmed; Naheed Ahmad; Aejaz Habeeb; Aleem A Khan; Niyaz Ahmed
Journal:  J Clin Microbiol       Date:  2005-04       Impact factor: 5.948

Review 3.  Helicobacter pylori in human health and disease: Mechanisms for local gastric and systemic effects.

Authors:  Denisse Bravo; Anilei Hoare; Cristopher Soto; Manuel A Valenzuela; Andrew Fg Quest
Journal:  World J Gastroenterol       Date:  2018-07-28       Impact factor: 5.742

4.  Pathogen evolution in vivo: genome dynamics of two isolates obtained 9 years apart from a duodenal ulcer patient infected with a single Helicobacter pylori strain.

Authors:  Valérie Prouzet-Mauléon; M Abid Hussain; Hervé Lamouliatte; Farhana Kauser; Francis Mégraud; Niyaz Ahmed
Journal:  J Clin Microbiol       Date:  2005-08       Impact factor: 5.948

5.  The intact dupA cluster is a more reliable Helicobacter pylori virulence marker than dupA alone.

Authors:  Sung Woo Jung; Mitsushige Sugimoto; Seiji Shiota; David Y Graham; Yoshio Yamaoka
Journal:  Infect Immun       Date:  2011-10-28       Impact factor: 3.441

Review 6.  Relatedness of Helicobacter pylori populations to gastric carcinogenesis.

Authors:  Quan-Jiang Dong; Shu-Hui Zhan; Li-Li Wang; Yong-Ning Xin; Man Jiang; Shi-Ying Xuan
Journal:  World J Gastroenterol       Date:  2012-12-07       Impact factor: 5.742

7.  Infection with specific Helicobacter pylori-cag pathogenicity island strains is associated with interleukin-1B gene polymorphisms in Venezuelan chronic gastritis patients.

Authors:  Miguel Angel Chiurillo; Yeinmy H Moran; Miryan Cañas; Elvis J Valderrama; Emma Armanie
Journal:  Dig Dis Sci       Date:  2010-06-29       Impact factor: 3.199

8.  Ethnicity association of Helicobacter pylori virulence genotype and metronidazole susceptibility.

Authors:  Hanafiah Alfizah; Awang Hamat Rukman; Ahmad Norazah; Razlan Hamizah; Mohamed Ramelah
Journal:  World J Gastroenterol       Date:  2013-02-28       Impact factor: 5.742

9.  CagA EPIYA polymorphisms in Colombian Helicobacter pylori strains and their influence on disease-associated cellular responses.

Authors:  Carlos Alberto Fajardo; Andrés Javier Quiroga; Andrea Coronado; Karen Labrador; Nicole Acosta; Pilar Delgado; Carlos Jaramillo; María Mercedes Bravo
Journal:  World J Gastrointest Oncol       Date:  2013-03-15

10.  Determination of Helicobacter pylori virulence by analysis of the cag pathogenicity island isolated from Iranian patients.

Authors:  K Baghaei; L Shokrzadeh; F Jafari; H Dabiri; Y Yamaoka; M Bolfion; H Zojaji; M M Aslani; M R Zali
Journal:  Dig Liver Dis       Date:  2009-03-03       Impact factor: 4.088

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.